SCHEMBL25915799

SCHEMBL25915799

CC(C)(C)c1cnc2n(c1=O)CCCC2

nearest known ligand 0.43

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
MAPK1 P28482 2/20 0.43
SMN1; SMN2 Q16637 4/20 0.40
ALDH1A1 P00352 3/20 0.40
HPGD P15428 3/20 0.40
MEN1 O00255 2/20 0.40
KMT2A Q03164 2/20 0.40
LMNA P02545 2/20 0.40
HTT P42858 2/20 0.40
HDAC6 Q9UBN7 1/20 0.40
KDM4E B2RXH2 1/20 0.40
NPC1 O15118 1/20 0.40
MAPT P10636 1/20 0.40
NPSR1 Q6W5P4 1/20 0.40
TDP1 Q9NUW8 1/20 0.40
POLB P06746 1/20 0.39
AR P10275 1/20 0.36
RAB9A P51151 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25735678 0.78 MAPK1 (0.50) MAPK1SMN1; SMN2ALDH1A1HPGDMEN1
SCHEMBL10183044 0.76 MAPK1 (0.47) MAPK1SMN1; SMN2ALDH1A1HPGDMEN1
SCHEMBL27414736 0.75 MAPK1 (0.44) MAPK1SMN1; SMN2ALDH1A1HPGDMEN1
Hydrochloric Acid SCHEMBL11189485 0.75 MAPK1 (0.51) MAPK1SMN1; SMN2ALDH1A1HPGDMEN1
SCHEMBL10183602 0.75 MAPK1 (0.50) MAPK1SMN1; SMN2ALDH1A1HPGDMEN1
SCHEMBL15042238 0.73 MAPK1 (0.40) MAPK1SMN1; SMN2ALDH1A1HPGDMEN1
SCHEMBL11092210 0.73 SMN1; SMN2 (0.45) MAPK1SMN1; SMN2ALDH1A1HPGDMEN1
SCHEMBL11183146 0.71 ALDH1A1 (0.43) MAPK1SMN1; SMN2ALDH1A1HPGDMEN1
SCHEMBL6683908 0.71 MAPK1 (0.40) MAPK1SMN1; SMN2ALDH1A1HPGDMEN1
SCHEMBL10183038 0.70 AR (0.44) MAPK1SMN1; SMN2ALDH1A1HPGDMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023125812-A1 SUBSTITUTED PYRIMIDONE DERIVATIVE, AND PHARMACEUTICAL COMPOSITION AND MEDICAL USE THEREOF 上海海雁医药科技有限公司 2023-07-06 WO disclosed